SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
iHuman Inc. (IH) trades at a trailing P/E of 1.3. Trailing earnings yield is 78.90%. Graham Number is $142.80.
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (1.3); earnings yield beats bond yields (78.90%).
- Trailing Earnings Yield 78.90% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 77/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — IH
Valuation Multiples
P/E (TTM)1.3
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.12
P/S Ratio0.15
EV/EBITDA-15.3
Per Share Data
EPS (TTM)$9.30
Book Value / Share$97.43
Revenue / Share$78.59
FCF / Share$0.00
Yields & Fair Value
Earnings Yield78.90%
Dividend Yield4.93%
Graham Number$142.80
SharesGrow IV$42.98 (+2342%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2018 |
-66.6 |
0.00 |
-18.41 |
8.90 |
0.93% |
| 2019 |
-4.3 |
0.00 |
-82.21 |
5.43 |
0.26% |
| 2020 |
-28.6 |
0.36 |
1.67 |
2.01 |
6.17% |
| 2021 |
-5.1 |
0.14 |
0.31 |
0.20 |
- |
| 2022 |
1.7 |
0.00 |
0.25 |
0.19 |
- |
| 2023 |
1.3 |
0.02 |
0.24 |
0.23 |
- |
| 2024 |
1.3 |
-0.03 |
0.13 |
0.14 |
27.28% |
| 2025 |
1.6 |
-0.51 |
0.15 |
0.19 |
4.05% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2018 |
$-1.72 |
$131.87M |
$-17.6M |
-13.3% |
| 2019 |
$-25.85 |
$218.66M |
$-275.6M |
-126% |
| 2020 |
$-5.05 |
$531.92M |
$-37.48M |
-7% |
| 2021 |
$-3.43 |
$944.72M |
$-37.05M |
-3.9% |
| 2022 |
$10.35 |
$985.52M |
$109.82M |
11.1% |
| 2023 |
$16.50 |
$1.02B |
$180.91M |
17.8% |
| 2024 |
$9.20 |
$922.2M |
$98.59M |
10.7% |
